Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0011 | 1 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |